Sun Pharmaceutical Industries Ltd - Stock Price

As on30 Jul 2021
  • NSE : SUNPHARMA
  • BSE : 524715
  • ISIN CODE : INE044A01036
  • Industry : Pharmaceuticals & Drugs
  • House : Sun Pharma
Sun Pharmaceutical Industries Ltd is not traded on BSE/NSE
NSE
773.95
+10.09 %+70.95
BSE
774.00
+10.06 %+70.75

Ratios

Parameter MAR 20  MAR 19  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)15.6911.1141.25
   CEPS(Rs)26.0120.6825.73
   DPS(Rs)4.002.7545.45
   Book NAV/Share(Rs)188.66172.599.31
   Tax Rate(%)16.4215.774.15
Margin Ratios
   Core EBITDA Margin(%)11.7411.145.39
   EBIT Margin(%)8.947.7515.37
   Pre Tax Margin(%)8.436.7624.65
   PAT Margin (%)7.055.7023.68
   Cash Profit Margin (%)10.508.8119.20
Performance Ratios
   ROA(%)6.585.1727.41
   ROE(%)9.668.0520.00
   ROCE(%)10.078.6816.06
   Asset Turnover(x)0.930.913.02
   Sales/Fixed Asset(x)1.781.92-7.42
   Working Capital/Sales(x)3.734.10-9.19
Efficiency Ratios
   Fixed Capital/Sales(x)0.560.528.01
   Receivable days56.2254.103.92
   Inventory Days48.4047.841.19
   Payable days63.3277.81-18.61
Valuation Parameters
   PER(x)22.4443.14-47.97
   PCE(x)13.5423.17-41.55
   Price/Book(x)1.872.78-32.77
   Yield(%)1.140.5797.92
   EV/Net Sales(x)2.634.07-35.36
   EV/Core EBITDA(x)11.3216.12-29.78
   EV/EBIT(x)16.2527.08-39.99
   EV/CE(x)1.331.90-30.27
   M Cap / Sales2.573.96-34.95
Growth Ratio
   Net Sales Growth(%)12.9810.0329.33
   Core EBITDA Growth(%)3.9913.75-70.97
   EBIT Growth(%)21.699.23134.98
   PAT Growth(%)30.4624.9821.94
   EPS Growth(%)41.2527.1951.74
Financial Stability Ratios
   Total Debt/Equity(x)0.180.25-27.65
   Current Ratio(x)2.021.7912.48
   Quick Ratio(x)1.511.3413.24
   Interest Cover(x)17.557.86123.20
   Total Debt/Mcap(x)0.100.097.61

About Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. was incorporated in the year 1993. Its today's share price is 774. Its current market capitalisation stands at Rs 185708.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 138365 Cr and Total Income of Rs.140428.5 Cr. The company's management includes Rama Bijapurkar, Pawan Goenka, Sunil R Ajmera, Gautam Doshi, Vivek Chaand Sehgal, Rekha Sethi, Sudhir V Valia, Kalyanasundaram Subramanian, Sailesh T Desai, Dilip S Shanghvi, Israel Makov.

It is listed on the BSE with a BSE Code of 524715 , NSE with an NSE Symbol of SUNPHARMA and ISIN of INE044A01036. It's Registered office is at Sun Pharma Advanced Research Centre (S P A R C),Tandalja,Vadodara-390020, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells, Price Waterhouse, SRBC & Co LLP

Latest News

close